Diabetes, obesity, CVD—all have been linked to disruption of the day-night rhythm caused by shift work. More facts and some tips for your shift-weary patients, here.
Veronica Hackethal, MD
These two new drugs for Alzheimer disease, presented at AAN 2015, are too good not to review. Here, a 6-slide summary of aducanumab and encenicline studies.
Lactose, fructose, FODMAPs are out. Cashew milk, bok choy, and taro are in. Get more, here, on ins, outs, and newest Rx for IBS.
Triptan and ergotamine drugs are staples of acute migraine treatment. But questions about their cardiovascular safety linger in the absence of clear evidence. A short slide show looks at what we do know.
It's probably too early to pass judgment but data from clinical trials point to decreased bone mineral density and increased treatment-emergent fractures in patients taking the new antidiabetes drugs.
Making a good match between a young patient and an inhaler device is a first step toward optimal asthma management. Find a brief review of how to make that match in this short slide show.